Assertio Holdings | DEPO - Sales Revenues

Stock Price
18.01
Daily Change
-0.01 -0.06%
Monthly
31.65%
Yearly
101.96%
Q2 Forecast
17.53

Assertio Holdings reported $29.2M in Sales Revenues for its fiscal quarter ending in September of 2024.





Sales Change Date
ANI Pharmaceuticals USD 247.06M 19.25M Dec/2025
Assertio Holdings USD 29.2M 1.92M Sep/2024
Aurora Cannabis CAD 94.19M 3.82M Dec/2025
Cara Therapeutics USD 2.57M 1.11M Mar/2025
Daiichi Sankyo JPY 558.11B 57.35B Dec/2025
Ironwood Pharmaceuticals USD 47.71M 74.35M Dec/2025
J&J USD 24.1B 500M Mar/2026
Knight Therapeutics CAD 133.11M 11.56M Dec/2025
Merck USD 16.4B 880M Dec/2025
Nektar Therapeutics USD 21.81M 2.32M Dec/2025
Pfizer USD 17.58B 880M Dec/2025
Teva Pharmaceutical Industries USD 14.63B 10M Dec/2025